The Global Non-invasive Prenatal Testing Market size is expected to reach US$ 14.48 billion by 2031. The market is anticipated to register a CAGR of 13.2% during 2025–2031. Increasing awareness of prenatal screening, rising maternal age, growing preference for non-invasive diagnostic procedures, and advancements in genomic technologies are supporting market expansion. Non-invasive...
The Global NGS Sample Preparation Market is expected to reach US$ 6,059 million by 2031. The market is anticipated to register a CAGR of 12.3% during 2025–2031. Increasing adoption of next-generation sequencing (NGS) technologies, growing demand for precision medicine, rising genomic research activities, and advancements in molecular diagnostics are driving market expansion. NGS sample...
Clinical Precision and Targeted Theranostics: Global Nuclear Medicine Market Set to Reach USD 18.87 Billion by 2030
Maximize Market Research, a global market intelligence, sector forecasting, and executive consulting powerhouse, has published a comprehensive industry analysis of the Global Nuclear Medicine Market. Valued at USD 7.22 Billion in 2023, the global nuclear medicine sector is on an...
Healthcare providers in the US are increasingly incorporating genomic technologies into prenatal screening strategies. Improvements in sequencing, data interpretation, and laboratory automation are helping expand the availability of advanced testing services. Greater integration of genetic screening into routine prenatal care is supporting continued market development.
The Non-invasive...
Global Lab-on-a-Chip Market Set to Surpass USD 16.37 Billion Driven by Decentralized Point-of-Care Diagnostics, Microfluidic Drug Discovery, and Organ-on-Chip Breakthroughs
The international life sciences, clinical diagnostics, and biotechnology ecosystems are undergoing an architectural transition toward micro-scale operational integration. According to an extensive industry evaluation...
The North America DNA Extraction, Isolation and Purification Market is witnessing significant growth, driven by the increasing adoption of molecular diagnostics, expanding genomics and proteomics research, and rising demand for precision medicine across the United States and Canada. The region benefits from advanced laboratory infrastructure, substantial investments in biotechnology...
According to the latest report published by Data Bridge Market Research, the Diagnostic and Testing Equipment Market
The global diagnostic and testing equipment market size was valued at USD 51.09 billion in 2024 and is expected to reach USD 74.90 billion by 2032, at a CAGR of 4.90% during the forecast period.
Getting thoughtful about competitive landscape is another significant...
According to the latest report published by Data Bridge Market Research, the Liquid Biopsy Tests Market
The global liquid biopsy tests market size was valued at USD 673.2 Million in 2025 and is expected to reach USD 2347.79 Million by 2033, at a CAGR of 16.90% during the forecast period
The large scale Liquid Biopsy Tests Market report is produced with...
According to the latest report published by Data Bridge Market Research, the Preimplantation Genetic Screening (PGS) Technology Market
The global Preimplantation Genetic Screening (PGS) technology market size was valued at USD 823.72 million in 2025and is expected to reach USD 1,830.95 million by 2033, at a CAGR of 10.50% during the forecast period
An influential...
According to the latest report published by Data Bridge Market Research, the Liquid Biopsy Tests Market
The global liquid biopsy tests market size was valued at USD 673.2 Million in 2025 and is expected to reach USD 2347.79 Million by 2033, at a CAGR of 16.90% during the forecast period
The supreme Liquid Biopsy Tests Market research report...
